For research use only. Not for therapeutic Use.
Cabazitaxel-d6 is a deuterated analog of the chemotherapeutic agent cabazitaxel, essential for advanced pharmaceutical and biochemical research. Featuring six deuterium atoms, it offers enhanced stability and precision in mass spectrometry and NMR spectroscopy. This isotopically labeled compound is crucial for studying the pharmacokinetics, metabolism, and mechanism of action of cabazitaxel. It ensures accurate quantification and reliable analytical results, making it an ideal standard for high-precision research in drug development, cancer therapy, and the investigation of metabolic pathways and resistance mechanisms in chemotherapeutic treatments.
| Catalog Number | R053229 |
| CAS Number | 1383561-29-2 |
| Synonyms | (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-(dimethoxy-d6)-4a,8,13,13-tetramethyl-5-ox |
| Molecular Formula | C45H57NO14 |
| Purity | ≥95% |
| Target | Cytoskeleton |
| Storage | Store at RT |
| InChI | InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1/i9D3,10D3 |
| InChIKey | BMQGVNUXMIRLCK-YHVGWTKXSA-N |
| SMILES | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC |
